BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2000
View Archived Issues
Cambridge Antibody Technology reports recent developments
Read More
Despite positive phase II results, Medivir must seek new partner for ME-609
Read More
Herceptin enters phase III trial as adjuvant therapy in early-stage breast cancer
Read More
Health Canada clears Enbrel for moderately to severely active RA
Read More
FDA approves second indication for Antizol
Read More
FDA clearance allows Amarin to begin Huntington's disease trials
Read More
Plan B emergency contraceptive now available in Canada
Read More
Tamiflu approved in Japan
Read More
Altered peptide ligand agreement between Neurocrine Biosciences and Taisho expanded
Read More
Berlex now marketing Levulan Kerastick photodynamic therapy in U.S.
Read More
Bronchial effects of prostanoid DP antagonist reported at Japanese Society of Allergology meeting
Read More
Kaken presents dual LTD4 and TxA2 antagonist with promising antiasthmatic profile
Read More
In vitro and in vivo characterization of the newly synthesized thrombin inhibitor AT-1362
Read More
Merck & Co. obtains rights to Probiodrug's DP-IV inhibitors for diabetes
Read More
AstraZeneca's rosuvastatin will be sold as Crestor
Read More
CeNeS shareholders approve acquisition of Cambridge NeuroScience
Read More
New agent for atopic dermatitis is endowed with antihistaminic and antiinflammatory effects
Read More
Quinoxalinecarboxylic acid-based AMPA receptor antagonists with good solubility characteristics
Read More
SmithKline Beecham terminates lotrafiban clinical development
Read More
AHP and Ligand collaboration focuses on progesterone receptor modulators
Read More
Aza compounds synthesized at Georgetown U. inhibit monoamine neurotransmitter reuptake
Read More
Cardiovascular agents useful for hypertension and ischemic disorders discovered at CSIR
Read More
Recent Japanese patent reveals new TNF-alpha inhibitors from Snow Brand
Read More
Pola's new ACAT inhibitors described in patent literature
Read More
Taisho discovers new histamine H2 antagonist with antisecretory activity
Read More